Abstract
Maternal lymphocytes at the fetal–maternal interface play a key role in the immune acceptance of the allogeneic fetus. Decidual NK cells have shown to contain immune modulatory properties and may facilitate fetal trophoblast invasion into maternal tissue. More recently, CD4+CD25 brightFOXP3+ Treg cells have been shown to be concentrated in decidual tissue and to be able to suppress both fetus-specific and nonspecific responses. However CD8+ T cells form the largest fraction of T cells at the fetal–maternal interface and are the main candidates to recognize and respond to fetal–maternal HLA differences. So far limited data are available on the phenotype and function of decidual CD8+ T cells during pregnancy. Phenotypic analysis of peripheral blood and decidual CD8+ T cells showed the presence of activated CD8+ T cells as well as a population of CD8+CD103+ T cells in decidual tissue. Unlike peripheral CD8+CD28− T cells, decidual CD8+CD28− T cells do not express the cytolytic molecule perforin. The lack of perforin expression may indicate that decidual CD8+ T cells are not able to elicit a cytotoxic response, and supports the hypothesis that decidual CD8+ T cells play a role in local immune regulation. Defects in decidual CD8+ T-cell regulation or differentiation may lead to placental pathologic conditions whereby placental and fetal growth are impaired.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
